Meet Neuland at CPHI India 2026 | Hall 2, Booth 2D38 | Yashobhoomi Convention Centre, New Delhi | 24-26 November 2026 Schedule a Meeting
Meet Neuland at CPHI India 2026 | Hall 2, Booth 2D38 | Yashobhoomi Convention Centre, New Delhi | 24-26 November 2026 Schedule a Meeting
Liquid phase peptide synthesis (LPPS), also known as solution-phase peptide synthesis, is a classical method for chemically assembling peptides in solution, one amino acid at a time.
In LPPS, the growing peptide stays dissolved in liquid, not attached to resin. Each amino acid addition cycle includes protecting reactive groups, coupling the next amino acid, and purifying the peptide before the next step.
This guide explains what LPPS is, how it differs from solid-phase peptide synthesis (SPPS), and discusses its methodology, advantages, limitations, and uses. It shows how LPPS fits into peptide manufacturing and drug development.
LPPS builds the peptide chain entirely in solution. Each step requires manual extraction and purification before proceeding, making it more labor-intensive. However, it’s still valuable when:
By contrast, SPPS, pioneered by R. Bruce Merrifield in the 1960s, anchors the first amino acid to a solid resin. This allows easy removal of excess reagents after each step via simple washing, eliminating the need to isolate intermediates. SPPS:
In short, SPPS trades some control for speed and scalability, while LPPS offers meticulous oversight and purity.
Modern peptide manufacturers, including Neuland Labs, often combine methods, using solution-phase techniques for short peptides, SPPS for longer chains, and hybrid approaches for very long or complex sequences. This adaptability helps meet varied project needs efficiently.
In LPPS, peptides are assembled through repeated solution-based chemical reactions following a defined amino acid sequence. Each cycle typically includes:
These steps repeat until the full sequence is built. After final deprotection, the crude peptide undergoes purification (often via HPLC) to reach the required purity.
LPPS can be:
Despite being more labor-intensive, LPPS offers unique benefits:
Here are some typical use cases and scenarios where LPPS or related solution-phase techniques play a key role:
For small peptides like dipeptides or tripeptides used in cosmetics, nutraceuticals, or intermediates, LPPS enables economical, large-scale production. Its compatibility with large volumes and crystallization makes it ideal for mass manufacturing.
LPPS plays a critical role in hybrid strategies. Segments (10–20 amino acids) are built via SPPS and later joined in solution using chemical ligation, essential for long peptides (>40 amino acids) or those with complex structures like multiple disulfide loops.
When ultra-high purity is required, especially for clinical or regulatory-grade material, LPPS offers tighter control. Purifying intermediates helps avoid side products, making it a preferred method for final-stage GMP manufacturing.
LPPS allows chemists to pause synthesis, modify the peptide in solution (e.g., add a lipid chain, fluorophore, or non-standard amino acid), purify the intermediate, and continue. This flexibility supports custom synthesis needs beyond SPPS’s limitations.
LPPS enables solution-phase couplings like peptide-drug or peptide-polymer conjugations. Methods such as native chemical ligation also occur in solution, making LPPS vital for assembling therapeutic conjugates and engineered peptides.
Liquid phase peptide synthesis remains an important technique in the peptide chemist’s arsenal. It offers unparalleled control and can achieve exceptional purity, which is crucial for certain applications in biotech and pharma. However, it also requires considerable effort and expertise.
If you’re evaluating custom peptide synthesis services or planning to scale up a peptide drug candidate, it’s wise to work with a partner experienced in all techniques. Neuland Labs has 4 decades of peptide manufacturing know-how and capabilities spanning solution-phase, solid-phase, and fragment condensation methods.
By offering end-to-end custom peptide synthesis services from milligram-scale research peptides to multi-kilogram GMP production, Neuland Labs can apply the approach that best fits your project’s requirements.
LPPS retains the classical control and purification rigor of early chemistry, while enabling adaptations like fragment condensation seen in solid-phase workflows. This hybrid flexibility helps optimize both peptide chain elongation and final peptide purification.
For short or mid-length peptides, LPPS enables high-yield production with scalable purification steps like crystallization. This makes it a strong option in peptide manufacturing, particularly when purity and volume matter more than automation.
Yes. With proper documentation, validated protocols, and intermediate testing, LPPS can support custom peptide synthesis under full GMP conditions, especially for smaller, high-purity APIs used in clinical or commercial drug development.
LPPS allows for tailored solvent selection, minimized reagent excess, and efficient peptide purification, often via crystallization. While SPPS generates more solid waste, LPPS can be designed for greener peptide synthesis through process optimization.
